Last edition
News about
Waters Launches First Extended-Range MALS Detector for UHPLC/UPLC
Waters launches first extended-range MALS detector for UHPLC/UPLC, enabling faster large molecule analysis with improved molar mass accuracy, reduced sample use and lower solvent consumption.
US Food and Drug Administration Urges Compliance on Clinical Trial Reporting to Address Data Gaps
The US Food and Drug Administration has issued reminders to over 2,200 companies and researchers to submit clinical trial results, aiming to reduce reporting gaps and improve transparency in drug development.
Thermo Fisher Scientific Partners with HealthVerity to Advance Data-Driven Clinical Research
The collaboration between Thermo Fisher Scientific and Healthverity grants enterprise access to one of the largest real-world healthcare datasets, enabling AI-powered insights to improve clinical trials, evidence generation and patient outcomes.
MSN Laboratories Launches SEMABEST, India's First Semaglutide After Patent Expiry
MSN Laboratories launches SEMABEST, India’s first semaglutide post patent expiry, priced 50 percent lower than the innovator drug and available as a pre-filled pen for improved patient access.
European Commission Approves Dupixent for Young Children with Chronic Spontaneous Urticaria
The European Commission has expanded approval of Dupixent to children aged 2–11 with chronic spontaneous urticaria, offering a targeted treatment for those unresponsive to standard antihistamines.
NIH-Funded Study Unveils Compact CRISPR System for Targeted In-Body Gene Editing
Researchers backed by the National Institutes of Health have developed an enhanced CRISPR enzyme that enables efficient gene editing and fits into viral delivery systems, advancing potential in-body therapies.
Partner Therapeutics Submits sBLA to FDA for BIZENGRI
Partner Therapeutics submits sBLA to FDA for BIZENGRI in NRG1 fusion-positive cholangiocarcinoma, supported by eNRGy study data showing 36.8 percent response rate and durable efficacy.
UK MHRA Approves Single-Dose 7.2mg Wegovy Injection for Obesity Treatment
The UK Medicines and Healthcare products Regulatory Agency has approved a single-dose 7.2mg Wegovy pen, simplifying weekly treatment for adults with obesity and a BMI of 30 or higher.
Kazia Expands Oncology Platform with First-in-Class SETDB1 Inhibitor
Kazia Therapeutics expands its oncology platform with a first-in-class SETDB1 inhibitor, leveraging an AI-driven epigenetic drug discovery engine for faster and scalable candidate development.
Roche Secures CE Mark for Blood-Based Test to Monitor Multiple Sclerosis
Roche’s Elecsys NfL test receives CE approval, offering a simple blood-based method to detect neuroinflammation in multiple sclerosis, improving monitoring access and supporting more timely, personalised disease management.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy